4.5 Letter

Soluble TRAIL does not impair the anti-osteoclastic activity of osteoprotegerin

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

The death receptor DR5 is involved in TRAIL-mediated human osteoclast apoptosis

Silvia Colucci et al.

APOPTOSIS (2007)

Review Biochemistry & Molecular Biology

The role of the TRAIL/TRAIL receptors system in hematopoiesis and endothelial cell biology

Giorgio Zauli et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2006)

Article Biochemistry & Molecular Biology

Death receptors, Fas and TRAIL receptors, are involved in human osteoclast apoptosis

S Roux et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)

Article Endocrinology & Metabolism

Human bone marrow stromal cells protect prostate cancer cells from TRAIL-induced apoptosis

R Nyambo et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2004)

Review Multidisciplinary Sciences

Osteoclast differentiation and activation

WJ Boyle et al.

NATURE (2003)

Article Biochemistry & Molecular Biology

Temperature-sensitive differential affinity of TRAIL for its receptors - DR5 is the highest affinity receptor

A Truneh et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2000)